When was Albireo Pharma, Inc. founded?
Albireo Pharma, Inc. was founded in 2008.
Where are Albireo Pharma, Inc. headquarters?
Albireo Pharma, Inc. headquarters are in Boston, Massachusetts, United States.
What sector does Albireo Pharma, Inc. operate in?
Albireo Pharma, Inc. is in biotechnology sector.
Is Albireo Pharma, Inc. a public company?
Yes, Albireo Pharma, Inc. is a public company.
What does Albireo Pharma, Inc. Do ?
Albireo pharma is a clinical-stage biopharmaceutical company focused through its operating subsidiary on the development of novel bile acid modulators to treat orphan pediatric liver diseases, and other liver and gastrointestinal diseases and disorders. albireo’s lead product candidate, a4250, is directed to treat rare pediatric cholestatic liver diseases and is in phase 3 development in its initial target indication, progressive familial intrahepatic cholestasis. albireo’s clinical pipeline also includes two phase 2 product candidates. albireo’s elobixibat, approved in japan for the treatment of chronic constipation, is the first ileal bile acid transporter (ibat) inhibitor approved anywhere in the world. albireo was spun out from astrazeneca in 2008. albireo pharma is located in boston, massachusetts, and its key operating subsidiary is located in gothenburg, sweden. for more information on albireo, please visit www.albireopharma.com.
What does Albireo Pharma, Inc. specialize into ?
We are not able to find any specialities related to Albireo Pharma, Inc. at the moment.
Who is the CEO of Albireo Pharma, Inc. ?
We do not have the information about the CEO of Albireo Pharma, Inc.. Our systems are trying to find it, we will update it as soon as we have it.
Try Mr. E's contact finder tool and fetch direct mobile numbers of decision-makers of all companies globally. Grow your sales now.
Free Trial with 5 contacts. No Credit Card Required. One-click Signup.